MBSCMBSC.CA,0P0000AZ4A,3146

🇪🇬 EGX
263.00
EGP
Analysis Scores
Lothien Robustness Score?
-
Neden bu skor?
Damodaran ?
-
Dalio Risk ?
-
Piotroski ?
5/9
Neutral
Previous year paid capital data missing (C7)
Graham ?
Veri Yetersiz
Ödenmiş sermaye verisi yok — hisse başı değer hesaplanamaz
Lothien Robustness Summary
58/100
Lothien Sağlamlık: Orta (58/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 2 | Negatif: 1 | Nötr: 0
Net Kâr Pozitif
Son çeyrekte E£591M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-68.6 geriledi (E£1.9B → E£591M). Kısa vadede olumsuz sinyal.
4 Çeyrek Üst Üste Artış
Son 4 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.

Data date date not measured Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date date not measured
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
252 days
Annual Volatility ?
%61.1
VaR 95% ?
%5.81
daily max loss
VaR 99% ?
%8.44
daily max loss
CVaR 95% ?
%5.66
expected loss (tail)
Max Drawdown ?
%19.4
17.06.2025 → 23.06.2025
Skewness ?
2.35
Parametrik%5.81
Historik%3.99
Cornish-Fisher%2.12
Return Distribution
Valuation
Potential?
-
Balance Sheet Analysis? Q2026/3
Net kâr çeyreklik %-68.6 düşerek 591.0M EGP oldu
Yıllık net kâr büyümesi sınırlı (%+2.9)
FAVÖK çeyreklik %-18.5 düştü (740.8M EGP)
İşletme nakit akışı pozitif: 449.9M EGP
ROE: %11.5
ROA güçlü: %8.7 — varlıklar etkin kullanılıyor
Son 8 çeyrek ardışık kâr
Fiyat TRAMA-99 üzerinde: %+17.6 — teknik trend olumlu
Destek seviyesi: TRAMA-99 = 223.68 EGP
Fundamental & Technical Analysis
Profitability
ROE - Return on Equity (TTM) %96.0
ROE %96.0 — high return on equity.
Valuation
No sector data
Indebtedness
No balance sheet data
Growth
Net Profit Growth (YoY) %+2.9
Net profit YoY %2.9 increased — positive but moderate growth.
Seasonality Analysis Q4 (Eki-Ara)
Historically strongest quarter: Q4 (Oct-Dec) (avg. profit 807.5M). Weakest quarter: Q2 (Apr-Jun) (avg. profit 279.4M).
Score Explanations
Piotroski F-Score
5/9
Moderate Piotroski (5/9). Some balance sheet criteria met, some missing. Note: Previous year paid capital data missing (C7)
Neutral
Graham Intrinsic Value
—
TRAMA-99 Trend — Strong Uptrend
Price (263.00), TRAMA-99 line's %17.6 above. Strong uptrend continues. Technical momentum positive.
Price:: 263.00
TRAMA: 223.68
Difference: %+17.6
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
MBSC — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.